These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21958454)

  • 21. Clinical conference: management of rare events following dermal fillers--focal necrosis and angry red bumps.
    Narins RS; Jewell M; Rubin M; Cohen J; Strobos J
    Dermatol Surg; 2006 Mar; 32(3):426-34. PubMed ID: 16640693
    [No Abstract]   [Full Text] [Related]  

  • 22. Healing of recalcitrant facial dermatitis by resting the skin.
    Gaul LE
    Cutis; 1981 Aug; 28(2):212-4. PubMed ID: 6456872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology.
    Mamelak AJ; Katz TM; Goldberg LH; Graves JJ; Kaye VN; Friedman PM
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1701-3. PubMed ID: 19807767
    [No Abstract]   [Full Text] [Related]  

  • 24. Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation.
    Pérez-Pérez L; García-Gavín J; Wortsman X; Santos-Briz Á
    Dermatol Surg; 2017 Apr; 43(4):605-608. PubMed ID: 27748693
    [No Abstract]   [Full Text] [Related]  

  • 25. Foreign body granuloma caused by hyaluronic acid/dextranomer microsphere filler injection.
    Yang JH; Lee SM; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Int J Dermatol; 2012 Dec; 51(12):1517-8. PubMed ID: 23171022
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.
    Arron ST; Neuhaus IM
    J Cosmet Dermatol; 2007 Sep; 6(3):167-71. PubMed ID: 17760694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed allergic hypersensitivity to hyaluronidase during the treatment of granulomatous hyaluronic acid reactions.
    Wu L; Liu X; Jian X; Wu X; Xu N; Dou X; Yu B
    J Cosmet Dermatol; 2018 Dec; 17(6):991-995. PubMed ID: 29159865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of hyaluronic acid injections triggering cutaneous sarcoidosis at previously treated sites.
    Mermin D; Loustalan MP; Doutre MS
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e55-e57. PubMed ID: 27357733
    [No Abstract]   [Full Text] [Related]  

  • 29. Self-injection of dermal filler: an underdiagnosed entity?
    Raoof N; Salvi SM
    Br J Dermatol; 2015 Mar; 172(3):782-3. PubMed ID: 25109339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy.
    Darling MD; Peterson JD; Fabi SG
    Dermatol Surg; 2014 Sep; 40(9):1049-52. PubMed ID: 25077741
    [No Abstract]   [Full Text] [Related]  

  • 31. Another cause of the butterfly rash.
    Shilo S
    Postgrad Med; 1991 Oct; 90(5):38, 40. PubMed ID: 1833728
    [No Abstract]   [Full Text] [Related]  

  • 32. Filler complications.
    Junkins-Hopkins JM
    J Am Acad Dermatol; 2010 Oct; 63(4):703-5. PubMed ID: 20846569
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.
    Chu CY
    Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676
    [No Abstract]   [Full Text] [Related]  

  • 34. Follicular mucinosis associated with imatinib (STI571).
    Yanagi T; Sawamura D; Shimizu H
    Br J Dermatol; 2004 Dec; 151(6):1276-8. PubMed ID: 15606531
    [No Abstract]   [Full Text] [Related]  

  • 35. Four flushers: topical agents producing facial flushing simulating the systemic variety.
    Fisher AA
    Cutis; 1993 Apr; 51(4):225-7. PubMed ID: 8477599
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphodiesterase-5 inhibitors and rosacea: report of 10 cases.
    Ioannides D; Lazaridou E; Apalla Z; Devliotou-Panagiotidou D
    Br J Dermatol; 2009 Mar; 160(3):719-20. PubMed ID: 19175601
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dermatitis of the face induced by etretinate].
    Manuzzi P; Reggiani M; Tosti A
    G Ital Dermatol Venereol; 1987 Mar; 122(3):129-30. PubMed ID: 2954901
    [No Abstract]   [Full Text] [Related]  

  • 38. Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report.
    Dammak A; Taillé C; Marinho E; Crestani B; Crickx B; Descamps V
    Br J Dermatol; 2012 Jun; 166(6):1375-6. PubMed ID: 22233356
    [No Abstract]   [Full Text] [Related]  

  • 39. Sirolimus-induced acneiform eruption.
    Kunzle N; Venetz JP; Pascual M; Panizzon RG; Laffitte E
    Dermatology; 2005; 211(4):366-9. PubMed ID: 16286750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facial filler and neurotoxin complications.
    Nettar K; Maas C
    Facial Plast Surg; 2012 Jun; 28(3):288-93. PubMed ID: 22723229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.